Dr. Reddy’s Laboratories Ltd. today announced its consolidated financial results for the fourth quarter and full year ended March 31, 2023. The information mentioned in this release is on the. | May 10, 2023
Hyderabad: Hyderabad-based Pharma giant Dr Reddy’s Lab on Wednesday reported a consolidated net profit of Rs 959 crore for the fourth quarter ended March 2023, up 996 percent over Rs 87.5 crore reported in the corresponding quarter in the previous year.
Zydus Lifesciences Limited has received final approval for Lubiprostone Capsules, 8 mcg and 24 mcg from the United States Food and Drug Administration.
On the Bombay Stock Exchange (BSE), 1037 stocks advanced, 2454 declined and 139 remained unchanged with advance decline ratio of 0.42, indicating a negative closing of stocks in broader markets.